Accelerate Program Success with Data-Driven Human Target Validation
AI enriched with patient data to reduce development risk, shorten timelines, boost asset value, and improve patient outcomes.
Transforming data and science into scalable impact and purposeful growth
We focus on indication selection and asset value maximisation
Numbers driving a brighter future for patients
Delivering innovation in indication finding
We combine advanced AI and domain expertise to inform smarter, faster decisions in early drug development.
Our platform integrates real-world data and the full landscape of relevant evidence to guide strategic choices—like indication selection—with greater confidence and clarity.
Launched in Switzerland in 2024, our team brings over 100 years in combined, proven experience in clinical research, data science, and finance to accelerate innovation and unlock asset value.
200B+
(DATA POINTS)
Integrated patient-level health and genomic data with literature, pipeline programs, and layered financial intelligence
100M+
(PATIENTS)
Access to rich, privacy-compliant electronic health and medical records
2x
(VALUATION)
Minimum quantified increase in asset valuation resulting from our services
5+
(Countries)
Worldwide presence fostering value growth globally
4
(Weeks)
Faster delivery compared to traditional approaches' monthly timelines
Strategic services when and where it counts
Analysis, strategy, and advisory of programs
We evaluate your assets and objectives to strategically guide your program’s roadmap, delivering and executing a targeted indication strategy supported by advanced technologies, rich data, and a trusted network of experts to accelerate progress and maximize impact.
Swiss-based
Global operations
Indication Strategy
Empowering Life Sciences leaders with AI-powered insights from robust, end-to-end data—patient-level to literature—to drive smarter development, sharper investments, lower risk, and faster growth.
Buy-, Sell-Side Advisory
Shaped by our Indication Strategy solution, we align interests and de-risk execution to unlock value—delivering data-driven recommendations that maximize asset monetization.
Client testimony
They trust us
Visionaries shaping impact
Meet the Minds Driving Innovation
Discover why we are your top choice, submit your request.
